Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ALT

Altimmune (ALT)

Altimmune Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALT

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next >>

Date	Time	Source	Headline	Symbol	Company
12/13/2021	6:00AM	GlobeNewswire Inc.	Altimmune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ALT	Altimmune Inc
11/22/2021	4:01PM	GlobeNewswire Inc.	Altimmune to Present at Upcoming Investor and Scientific Conferences	NASDAQ:ALT	Altimmune Inc
11/10/2021	4:01PM	GlobeNewswire Inc.	Altimmune to Present at Upcoming Investor Conferences	NASDAQ:ALT	Altimmune Inc
11/09/2021	4:11PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
11/09/2021	4:01PM	GlobeNewswire Inc.	Altimmune Announces Third Quarter 2021 Financial Results and Provides a Corporate Update	NASDAQ:ALT	Altimmune Inc
11/03/2021	4:01PM	GlobeNewswire Inc.	Altimmune to Announce Third Quarter 2021 Financial Results on November 10, 2021	NASDAQ:ALT	Altimmune Inc
11/01/2021	7:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALT	Altimmune Inc
10/06/2021	4:01PM	GlobeNewswire Inc.	Altimmune to Present at Upcoming H.C. Wainwright Investor Conferences October 12-13, 2021	NASDAQ:ALT	Altimmune Inc
10/04/2021	7:00AM	GlobeNewswire Inc.	Altimmune Announces Initiation of 12-week Phase 1b Trial of Pemvidutide in Subjects with Non-Alcoholic Fatty Liver Disease	NASDAQ:ALT	Altimmune Inc
10/01/2021	7:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALT	Altimmune Inc
10/01/2021	7:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALT	Altimmune Inc
09/29/2021	6:15PM	GlobeNewswire Inc.	Altimmune to Host Key Opinion Leader Call with Dr. Stephen Harrison on Pemvidutide Phase 1 Clinical Trial Results on September 30, 2021	NASDAQ:ALT	Altimmune Inc
09/28/2021	7:11AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
09/28/2021	7:01AM	GlobeNewswire Inc.	Altimmune Announces Positive Results From 12-week Phase 1 Clinical Trial of ALT-801 (Pemvidutide) in Overweight and Obese Volunteers	NASDAQ:ALT	Altimmune Inc
09/27/2021	4:01PM	GlobeNewswire Inc.	Altimmune to Announce 12-Week Data From ALT-801 Phase 1 Trial on September 28, 2021	NASDAQ:ALT	Altimmune Inc
09/24/2021	5:27PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
09/07/2021	4:01PM	GlobeNewswire Inc.	Altimmune to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021	NASDAQ:ALT	Altimmune Inc
08/31/2021	7:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALT	Altimmune Inc
08/31/2021	11:04AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ALT	Altimmune Inc
08/16/2021	5:07PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ALT	Altimmune Inc
08/10/2021	4:08PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc
08/10/2021	4:01PM	GlobeNewswire Inc.	Altimmune Announces Second Quarter 2021 Financial Results and Provides a Corporate Update	NASDAQ:ALT	Altimmune Inc
08/06/2021	7:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALT	Altimmune Inc
08/06/2021	7:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALT	Altimmune Inc
08/06/2021	7:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALT	Altimmune Inc
08/04/2021	4:01PM	GlobeNewswire Inc.	Altimmune to Announce Second Quarter 2021 Financial Results on August 11, 2021	NASDAQ:ALT	Altimmune Inc
08/02/2021	7:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALT	Altimmune Inc
07/01/2021	7:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALT	Altimmune Inc
06/30/2021	5:46AM	TipRanks	Altimmune Not Immune to Poor Results; Drops AdCOVID Vaccine program	NASDAQ:ALT	Altimmune Inc
06/29/2021	4:31PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALT	Altimmune Inc

Showing the most relevant articles for your search:NASDAQ:ALT

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next >>

Northwest Biotherapeutics (QB)

Ethema Health (PK)

Asia Broadband (PK)

Kraig Biocraft Laborator... (QB)

1812 Brewing (PK)

Faraday Future Intellige...

Fannie Mae (QB)

SMC Entertainment (PK)

Bioelectronics (PK)

Anavex Life Sciences

Emergent Health (PK)

Digital Brand Media and ... (PK)

Branded Legacy (PK)

Delayed Upgrade Clock